Profound Medical Corp. (NASDAQ: PROF) reported Q4 EPS of $0.27, $0.57 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $6 million versus the consensus estimate of $7.9 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.